New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
09:24 EDTSQNM, AETSequenom could benefit meaningfully from Aetna decision, says Oppenheimer
After Aetna (AET) recommended measuring cell-free fetal nucleic acids when testing for Down's syndrome in at-risk women, Oppenheimer thinks the recommendation suggests that Aetna is likely to pick up coverage of Sequenom's MaterniT21. The firm reiterates an Outperform rating on Sequenom.
News For SQNM;AET From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 15, 2014
13:52 EDTAETAetna will not renew contract for Delaware Medicaid program
Subscribe for More Information
October 9, 2014
08:03 EDTAETWellPoint named top Managed Care pick at Jefferies
Subscribe for More Information
October 7, 2014
10:18 EDTSQNMHigh option volume stocks
Subscribe for More Information
09:24 EDTSQNMMaxim recommends buying Sequenom
Subscribe for More Information
09:01 EDTSQNMSequenom acquisition a strategic positive, says Maxim
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use